The current role of dual therapy for treatment of Helicobacter pylori: back to the future?

被引：13

作者：

Zullo, Angelo ^{[1
]}

机构：

[1] Nuovo Regina Margherita Hosp, Gastroenterol & Digest Endoscopy, Via Emilio Morosini 30, I-00153 Rome, Italy

来源：

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2020年 / 32卷 / 05期

关键词：

TRIPLE THERAPY; ERADICATION; METRONIDAZOLE; AMOXICILLIN; INFECTION; TRIAL; CURE;

D O I：

10.1097/MEG.0000000000001654

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：555 / 556

页数：2

共 14 条

[1] REGRESSION OF PRIMARY GASTRIC LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE TYPE AFTER CURE OF HELICOBACTER-PYLORI INFECTION [J].

BAYERDORFFER, E ;

NEUBAUER, A ;

RUDOLPH, B ;

THIEDE, C ;

LEHN, N ;

EIDT, S ;

STOLTE, M .

LANCET, 1995, 345 (8965) :1591-1594

[2] DOUBLE-BLIND TRIAL OF OMEPRAZOLE AND AMOXICILLIN TO CURE HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH DUODENAL-ULCERS [J].

BAYERDORFFER, E ;

MIEHLKE, S ;

MANNES, GA ;

SOMMER, A ;

HOCHTER, W ;

WEINGART, J ;

HELDWEIN, W ;

KLANN, H ;

SIMON, T ;

SCHMITT, W ;

BASTLEIN, E ;

EIMILLER, A ;

HATZ, R ;

LEHN, N ;

DIRSCHEDL, P ;

STOLTE, M .

GASTROENTEROLOGY, 1995, 108 (05) :1412-1417

[3]

De Francesco V, 2017, ANN GASTROENTEROL, V30, P373, DOI 10.20524/aog.2017.0166

[4] Efficacy and safety of high-dose dual therapy for Helicobacter pylori rescue therapy: A systematic review and meta-analysis [J].

Gao, Cai Ping ;

Zhou, Zhou ;

Wang, Jia Zhen ;

Han, Sheng Xi ;

Li, Liang Ping ;

Lu, Hong .

JOURNAL OF DIGESTIVE DISEASES, 2016, 17 (12) :811-819

[5]

GRAHAM DY, 1993, ALIMENT PHARM THERAP, V7, P111

[6] Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection [J].

Lopez-Gongora, Sheila ;

Puig, Ignasi ;

Calvet, Xavier ;

Villoria, Albert ;

Baylina, Mireia ;

Munoz, Neus ;

Sanchez-Delgado, Jordi ;

Suarez, David ;

Garcia-Hernando, Victor ;

Gisbert, Javier P. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (09) :2447-2455

[7] Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report [J].

Malfertheiner, P. ;

Megraud, F. ;

O'Morain, C. A. ;

Gisbert, J. P. ;

Kuipers, E. J. ;

Axon, A. T. ;

Bazzoli, F. ;

Gasbarrini, A. ;

Atherton, J. ;

Graham, D. Y. ;

Hunt, R. ;

Moayyedi, P. ;

Rokkas, T. ;

Rugge, M. ;

Selgrad, M. ;

Suerbaum, S. ;

Sugano, K. ;

El-Omar, E. M. .

GUT, 2017, 66 (01) :6-30

[8]

Malfertheiner P, 1997, GUT, V41, P8

[9] ATTEMPT TO FULFILL KOCH POSTULATES FOR PYLORIC CAMPYLOBACTER [J].

MARSHALL, BJ ;

ARMSTRONG, JA ;

MCGECHIE, DB ;

GLANCY, RJ .

MEDICAL JOURNAL OF AUSTRALIA, 1985, 142 (08) :436-439

[10] Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin [J].

Miehlke, S. ;

Hansky, K. ;

Schneider-Brachert, W. ;

Kirsch, C. ;

Morgner, A. ;

Madisch, A. ;

Kuhlisch, E. ;

Baestlein, E. ;

Jacobs, E. ;

Bayerdoerffer, E. ;

Lehn, N. ;

Stolte, M. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (02) :395-403

← 1 2 →